Literature DB >> 18045821

Calcium and potassium changes during haemodialysis alter ventricular repolarization duration: in vivo and in silico analysis.

Stefano Severi1, Eleonora Grandi, Chiara Pes, Fabio Badiali, Fabio Grandi, Antonio Santoro.   

Abstract

BACKGROUND: Alterations of ventricular repolarization duration, as measured by the QT interval, are frequently observed in haemodialysis (HD) patients. The nature and the sign of these changes are not yet fully understood.
METHODS: Different dialysate K(+) and Ca(2+) levels, leading to different end-HD plasma concentrations in the patient, have been tested in the present study in terms of their impact on QTc. A model of the human cardiomyocyte action potential (AP) has been used to assess in silico whether the changes in Ca(2+) and K(+) were able to justify at the cellular level the observed alterations of QTc.
RESULTS: QTc was prolonged in HDs with low (1.25 mM) versus high (2 mM) Ca(2+) (424 +/- 33 versus 400 +/- 28 ms, P < 0.05) and in HDs with low (2 mM) versus high (3 mM) K(+) (420 +/- 35 versus 399 +/- 36 ms, P < 0.05). These alterations were confirmed at the cellular level by computational analysis showing prolongation of ventricular AP at low K(+) and low Ca(2+) at the same extent of the measured QTc variations. Numerical simulation predicted a critically long AP (and QT) when considering low K(+) and Ca(2+) simultaneously, suggesting the concurrent lowering of Ca(2+) and K(+) as a potential arrhythmogenic factor.
CONCLUSIONS: Numerical simulations of the ventricular AP may be useful to quantitatively predict the complex dependence of AP duration on simultaneous changes in Ca(2+) and K(+). Moreover, Ca(2+) content in the dialysate should be designed not to critically lower serum Ca(2+), especially in sessions at risk of end-dialysis hypokalaemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045821     DOI: 10.1093/ndt/gfm765

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  18 in total

1.  Acute effect of a peritoneal dialysis exchange on electrolyte concentration and QT interval in uraemic patients.

Authors:  Simonetta Genovesi; Elisa Nava; Chiara Bartolucci; Stefano Severi; Antonio Vincenti; Gina Contaldo; Giada Bigatti; Daniele Ciurlino; Silvio Volmer Bertoli
Journal:  Clin Exp Nephrol       Date:  2019-08-19       Impact factor: 2.801

Review 2.  Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.

Authors:  Geoffrey K Isbister; Colin B Page
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

Review 3.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients.

Authors:  Patrick H Pun; John R Horton; John P Middleton
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-31       Impact factor: 8.237

5.  Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Authors:  Patrick H Pun; Safa Abdalla; Geoffrey A Block; Glenn M Chertow; Ricardo Correa-Rotter; Bastian Dehmel; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Gerard M London; Kenneth W Mahaffey; Sharon M Moe; Patrick S Parfrey; David C Wheeler; John P Middleton
Journal:  Hemodial Int       Date:  2015-11-13       Impact factor: 1.812

6.  Effect of citric-acid dialysate on the QTC-interval.

Authors:  Karlien J Ter Meulen; Ben J M Hermans; Frank M van der Sande; Bernard Canaud; Constantijn J A M Konings; Jeroen P Kooman; Tammo Delhaas
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

7.  QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory.

Authors:  Mohamed A Alabd; Walid El-Hammady; Ahmed Shawky; Wail Nammas; Mohamed El-Tayeb
Journal:  Nephron Extra       Date:  2011-07-09

8.  Low dialysate potassium and central arterial pressure waveform.

Authors:  Inga Soveri; Jaak Kals
Journal:  Ups J Med Sci       Date:  2015-05-07       Impact factor: 2.384

Review 9.  QT interval in CKD and haemodialysis patients.

Authors:  Biagio Di Iorio; Antonio Bellasi
Journal:  Clin Kidney J       Date:  2013-01-17

10.  Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH.

Authors:  Takahiro Kuragano; Minoru Furuta; Mana Yahiro; Aritoshi Kida; Yoshinaga Otaki; Yukiko Hasuike; Akihide Matsumoto; Takeshi Nakanishi
Journal:  BMC Nephrol       Date:  2013-01-18       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.